- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00550979
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
August 28, 2013 updated by: Rhonda Bentley-Lewis, MD, Brigham and Women's Hospital
The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers in women who have had a pregnancy complicated by diabetes as compared with women who have had a normal pregnancy.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
96
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Research Assistant
- Phone Number: 617-724-3504
- Email: RBLResearchGroup@partners.org
Study Contact Backup
- Name: Rhonda Bentley-Lewis, MD, MBA
- Phone Number: 617-726-2874
- Email: rbentleylewis@partners.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital, Massachusetts General Hospital
-
Principal Investigator:
- Rhonda Bentley-Lewis, MD
-
Sub-Investigator:
- Florence Brown, MD
-
Sub-Investigator:
- David Nathan, MD
-
Sub-Investigator:
- Mark Creager, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Black and white women who have had uncomplicated pregnancies or pregnancies complicated by gestational diabetes in the past 5 years
Description
Inclusion Criteria:
- Healthy women of self-identified African descent (black) and European (white) ancestry
- 18-40 years of age
- Regular menstrual cycles
- 5 or less years postpartum
- Have either a normal or a GDM index pregnancy history
- Are in good health free of thyroid, cardiac, or renal disease
Exclusion Criteria:
- If you are pregnant
- If you are lactating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
---|
1
Black women with history of pregnancy/ies complicated by gestational diabetes mellitus
|
2
Black women with history of normal, uncomplicated pregnancy/ies
|
3
White women with a history of pregnancy/ies complicated by gestational diabetes.
|
4
White women with a history of normal, uncomplicated pregnancy/ies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
endothelial function
Time Frame: same day
|
same day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rhonda Bentley-Lewis, MD, Brigham and Women's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Primary Completion (Anticipated)
October 1, 2013
Study Completion (Anticipated)
January 1, 2014
Study Registration Dates
First Submitted
October 26, 2007
First Submitted That Met QC Criteria
October 26, 2007
First Posted (Estimate)
October 30, 2007
Study Record Updates
Last Update Posted (Estimate)
August 29, 2013
Last Update Submitted That Met QC Criteria
August 28, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007P001406
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes Mellitus
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingGestational Diabetes Mellitus in PregnancyFrance
-
i-Health, Inc.CompletedGestational Diabetes Mellitus in PregnancyGermany
-
The Danish Center for Strategic Research on Type...Odense University HospitalCompletedGestational Diabetes Mellitus in PregnancyDenmark
-
Services Institute of Medical Sciences, PakistanCompletedGestational Diabetes Mellitus in PregnancyPakistan
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchTerminatedGestational Diabetes Mellitus in PregnancySingapore
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Federal State Budgetary Institution, V. A. Almazov...RecruitingGestational Diabetes Mellitus (GDM)Russian Federation